Eppendorf
  Editorial
 HOSTILE ENVIRONMENT IN HOSPITALS   
 Wednesday, May 12, 2021 
 Safety and security in hospitals have been a matter of great concern for quite some time in the country. 
  Past Editorial...  
MSC
TODAY'S NEWS
18:00  [IST]Antengene receives China NMPA approval to initiate phase Ib/II study of eltanexor in patients with advanced solid tumors
17:00  [IST]Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures
16:00  [IST]Seattle Cancer Care Alliance authorizes as a treatment center for Ide-cel CAR T-cell therapy
15:00  [IST]ReGenTree announces results of additional analysis of phase 3 clinical trial ARISE-3, using RGN-259 to treat dry eye syndrome
14:00  [IST]BD’s self-collection claim for HPV screening assay receives CE marking
13:00  [IST]WuXi Biologics, WuXi STA establish joint venture company, WuXi XDC to provide fully integrated bioconjugate CDMO services
more news >>
Pioma_Vegoil_tea
TOP NEWS
08:00  [IST]Indore drug units heave a sigh of relief as oxygen supply resumes
08:00  [IST]Traders in Sikkim face difficulties in bulk purchase of Covid-19 drugs including OTC products
08:00  [IST]DRM scouts for investors to upscale its Covid-19 drugs
08:00  [IST]NABH shares LoI format and TOR with prospective hospitals to be developed as AMCs under PvPI
08:00  [IST]Indian clinical trial companies showcase competence with tech adoption and M&As deals
08:00  [IST]Experts at IPC, CDSCO meet to outline plan for designing PV as per regional needs for setting up PV cell
more news >>
mettler
YESTERDAY'S NEWS
18:00  [IST]Antengene gets China NMPA approval to begin phase III trial of selinexor in advanced or recurrent endometrial cancer
14:40  [IST]Sattva Group offers oxygen bus on wheels to offset Karnataka access to oxygen for needy patients
14:30  [IST]Union government consistently working to enhance the availability of Covid vaccines
14:20  [IST]Alembic Pharma Q4 net profit rises 12% to Rs. 251 crore
14:10  [IST]Torrent Pharma enters into voluntary licensing agreement with Eli Lilly for baricitinib for Covid-19
13:50  [IST]SPARC announces positive top-line results from phase 3 trial of PDP-716 to treat open angle glaucoma
more news >>
INTERVIEW  
Indian pharma garners global recognition with its capability in Covid-19 vaccine
Dr. R. Ananthanarayanan, MD & CEO, Strides Pharma Science
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the IMA’s attitude of taking cudgels against Patanjali’s Coronil as a preventive and curative ayurveda medicine for Covid-19 justified?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
india
truking"
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |